Expert Opinion on Emerging Drugs

Expert Opin Emerg Drugs

1472-8214

1744-7623

Therapeutic Area

Pharmacology, Rare Diseases

Academics, Clinical Pharmacists, Clinical Pharmacologists, Clinicians, Managers, Pharmaceutical Benefits Managers, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Physicians - Medicine, Researchers, Scientists

Expert Opinion on Emerging Drugs [ISSN 1472-8214]; [e-ISSN 1744-7623] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Emerging Drugs addresses the needs of pharmaceutical and academic scientists, research planners, pharmaceutical product managers, clinical opinion leaders and healthcare planners. Articles include the following key areas: Concise background to the subject matter; Assessment of medical need for alternative or novel therapies; Assessment of the market and anticipated changes over time; Summary of current research goals; Outline of the scientific rationale for the approach(es) considered; Analysis of the competitive environment; Discussion of potential development issues; The author’s expert opinion on the potential impact emerging therapies will have on the current management of specific diseases.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines